Journal of Depression and Anxiety

Journal of Depression and Anxiety
Open Access

ISSN: 2167-1044

Research Article - (2018) Volume 7, Issue 4

A Case Series for Salmonella Carriers Who Presented with Psychosomatic Depressive Disorder and Showed Improvement after Ceftriaxone Treatment for 15 Days

Mohammed Saied Bakeer1*, Mohammed Salah Hussein1, Abd-El Aleem A. El-Gendy2 and Abouzed M3
1Department of Internal Medicine, Al-Azhar University, Cairo, Egypt
2Department of Clinical Pathology, Al-Azhar University, Cairo, Egypt
3Department of Psychiatry, Al-Azhar University, Cairo, Egypt
*Corresponding Author: Mohammed Saied Bakeer, Department of Internal Medicine, Al-Azhar University, Cairo, Egypt, Tel: 00201220481379 Email:

Abstract

Background: Based on our observations, as physicians in a Referral Hospital, we have been noticing the association between history of enteric fever and somatic disorders associated with low mood. At our hospital, Al- Hussein University Hospital, Cairo, Egypt, we are receiving patients from all over Egypt, including rural areas where enteric fever is endemic. Here we report this series for 15 patients referred to us for evaluation of different somatic disorders.
Clinical presentation: After extensive evaluations, the patients’ symptoms were proved to be functional, their typhoid carrier states were documented, they were evaluated for depression using Hamilton-D questionnaire and the severity of depression was recorded. All patients were treated by ceftriaxone, 2 g, IV, daily for 15 days. Clinical evaluation and Hamilton score were reassessed at the end of treatment and 6 weeks thereafter. The patients did not receive any anti-depressant nor anti-anxiety treatment during their course. Typhoid carrier was defined by documenting the history of typhoid fever that was diagnosed by culturing the Salmonella species not by serology, plus at least one occasion of Salmonella isolates from stool culture while afebrile, plus absence of fever in the past 3 weeks. The Widal test wasn’t accepted as a criterion for enrolment.
Results: Patients showed clinically significant improvement in term of the presenting somatic complaints as well as their Hamilton-D score immediately post-treatment and consolidate for 6 weeks post-treatment completion.
Conclusion: Typhoid carrier in our series was associated with psychosomatic depression that improved on antibiotic therapy.

Keywords: Typhoid carrier; Depression; Psychosomatic

Introduction

Typhoid fever is a global health problem, with approximately 21 million new cases infection by Salmonella typhi (S. typhi ) each year [1]. The mortality from typhoid fever increased by 39% between 1990 and 2010, with more than 190,000 persons die each year [2]. In South East Asia and Sub-Saharan Africa, it was estimated that the effect of typhoid fever in mortality is comparable to prostate, breast and leukaemia in western societies [2].

Approximately 2-5% of typhoid fever patients will turn to be chronic carriers [3], these carriers are asymptomatic, yet continue to excrete the organism for prolonged, ill-defined period and act as reservoirs for the organism [4]. Depression and low mood is associated with considerable morbidity and mortality [5] and it is expected to represent the second leading cause of disability worldwide by 2020, only after ischemic heart disease [6].

Chronic inflammatory disorders are associated with depression [7-10]. Excess levels of inflammatory cytokines; interleukin-1 (IL-1), interleukin-6 (IL-6), and interferon gamma (IFN-g), are associated with major depressive disorders [11]. Elevated level of Serum high sensitivity C-reactive protein was associated with increased risk of major depressive disorder [12]. The most striking observation, for the association between inflammatory cytokines and depression, comes from following hepatitis C patients, treated by interferon-α, which is an inflammatory cytokine. It was found that up to 50% of patients treated by interferon-α, developed clinically significant depression [13,14].

This inflammatory model of depression provides a possible link between the infection and depression. The association between typhoid fever and neuropsychiatric illness is documented in previous studies [15-17]. Through increasing inflammatory cytokines, typhoid vaccine was associated with significant short-term depression together with increased activity within the anterior cingulate cortex [18,19]. Our report is based mainly on our clinical observations as physicians in referral hospital in endemic country, Egypt.

Patients and Methods

Enrolment

This prospective cohort study describing 15 patients treated at Al- Hussein university hospital, Cairo, Egypt. The study time was from May 2015-September 2017. All patients were >18 years. Patients were refereed to us for evaluation of different somatic complaints. All patients were Egyptians and were coming from rural areas. They presented with combination of different somatic complaints. Table 1 shows the frequency of somatic complaints at presentation and 6 weeks after the end of treatment, see later.

Characteristics Cases number (%)
Sex 
Male 8 (53%)
Female 7 (47%)
Age, years, median (range) 47 (19-63)
Rural destinations 15 (100%)
Chronic diseases 
No 10 (66%)
DM 3 (20%)
HTN 4 (26%)
Asthma 1 (6%)
Smoking 
Yes 6 (40%)
No 9 (60%)
Positive examination findings at presentations, at 6th week point
Pallor 12 (80%), 3 (20%)
White coated tongue 12 (80%), 2 (13%)
Right iliac fossa tenderness by deep palpations 13 (86%), 1 (6%)
Imaging finding at presentations, at 6th week point 
Splenomegaly  
12-15 cm 8 (53%), 4 (26%)
>15 cm 0 (0%), 0 (0%)
Hepatomegaly 6 (40%), 6 (40%)
Thick wall gall bladder 12 (80%), 12 (80%)
Gall bladder stone 3 (20%), 3 (20%)
Laboratory finding
Leukocytes (× 103/μL), mean, (SD) 6.9 (3.6)
Hemoglobin (gm/dl), mean, (SD) 12.4 (1)
Platelets (× 103/μL), mean, (SD) 329.1 (159)
ALT (IU/L), mean, (SD) 46 (19.5)
AST (IU/L), mean, (SD) 42.5 (14.1)
Creatinine (mg/dL), mean (SD) 1.1 (0.2)
CRP (mg/L), mean (SD) 4 (1.3)
ESR (ml/hr), mean (SD) 16.1 (8.6)
Widal test positivity cutoff 1/160 13 (86%)
Bacteria isolated from stool culture 
S. typhi 10 (66%)
S. para-typhi A 5 (33%)
S. para-typhi B/C 0 (0%)
Time since the diagnosis of typhoid fever 
Chronic > 1 year 5 (33%)
Temporarily 3 months-1 year 8 (53%)
Convalescent 3 weeks-3 months 1 (6%)

Table 1: Basic, clinical, laboratory, radiological and microbiological data.

Exclusion criteria

• Past or family history of any psychiatric illness.

• Any form of drug addiction.

• Patients taking any psychotropic medications, including steroids (except for inhaled steroid), anti-depressant, anxiolytics and interferon treatment.

• Hypothyroidism, hypopituitarism, Cushing syndrome and hypocorticolism.

• Chronic kidney disease, liver failure, heart failure and respiratory failure.

• Active infections.

• Inflammatory collagen diseases.

• Malignancies.

• Pregnancy.

Clinical and investigational workup don for exclusion of organic diseases

Patients were subjected to full clinical assessment including history taking and thorough clinical examinations, supplemented by targeted laboratory, radiological and endoscopic assessment. Routine laboratory investigations were done supplemented as appropriate by more targeted investigations including complete blood count (CBC), liver functions, urinalysis, renal functions, blood sugar, electrolytes, thyroid function, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), anti-nuclear antibodies (ANA), calcium (Ca), serum protein electrophoresis, abdominal ultrasound, chest X-ray, echocardiography, resting and stress electrocardiography (ECG), computerized tomography (CT) abdomen and pelvis, upper and lower gastrointestinal (GIT) endoscopy. Clinical evaluation was done at the relevant specialized clinics at Al-Hussein university hospital, Cairo, Egypt and it was a routine work done while the evaluating physicians were not aware about the on-going study. Only after exclusion of organic causes were the patients enrolled. The medical records of the patients were reviewed, and the basic laboratory and radiological data were extracted and the positive clinical findings were recorded.

Case definition for typhoid carrier

• Typhoid carrier was defined as follow:

• No history of fever in the past 3 weeks and the body temperature was documented to be <37.5°C for >48 hours without antipyretics and the recoding done after inpatient admission.

• The history of enteric fever, diagnosed by appropriate culturing from blood, urine, stool or bone marrow was documented by reviewing the Patients’ medical records.

• At least one occasion of isolation of Salmonella typhi or Salmonella Para-typhi A, B or C from the stool of patients without fever.

• Throughout this article we did not differentiate between carriage of Salmonella typhi or Salmonella Para-typhi A, B or C, and we refer to all as typhoid carrier.

• All patients fulfilled all the above criteria.

Case identification of depression

The patients were evaluated using the standard clinical interview. The interview was conducted by an expert physician, under standard condition of optimum doctor-patient relationships. We used Hamilton Rating Scale for Depression (HAM-D) [20], which is a well validated questionnaire designed for assessing depression in adults. It uses some probing questions to assess the severity of depression; mood, guilty sensation, anxiety, weight loss, agitation, insomnia, somatic symptoms and suicidal ideation. The assessment is based on 17 items and each item is scored on 3 or 5 points. It is interpreted as follow:

• 0 - 7 = Normal

• 8 - 13 = Mild Depression

• 14-18 = Moderate Depression

• 19 - 22 = Severe Depression

• > 23 = Very severe depression

The score was recorded, for every patient, 3 times; on first assessment, at the end of antibiotics and 6 weeks after completion of antibiotics.

Consent and ethics

The study was approved by our local ethical committee. We obtained an informed, written consents from all patients.

Microbiological tests

Bacterial isolates from stool cultures were identified using the API 20E system (bioMérieux, Marcy l’Etoile, France).

Treatment and follow-up

After enrolment, we treated all patients empirically with intravenous ceftriaxone, 2 gram every 24 hours, for 14 days. No psychotropic drugs were given, only ceftriaxone. We adopted this protocol for all patients due to the high prevalence of ciprofloxacin resistant strains in Egypt (based on our clinical experiences).

Documenting recovery of carrier states

We documented clearance of carriage state through obtaining culture negative stool in 3 consecutive samples, taken 1 month after completion of antibiotic course, interestingly all patients showed stool culture negativity in the three samples.

Statistical analyses

All results were analysed using the Statistical Package for the Social Sciences (SPSS) program, version 23. Numerical data was expressed as mean ± standard deviation (SD) while categorical data was expressed as percentages. The Kolmogorov-Smirnov test was used to assess the normality of numerical data. Differences between two groups were compared using the Student's t-test for continuous variables, and the χ2 test or Fisher's exact test for categorical variables, as appropriate. Two pair t-test was applied to determine the mean differences and the significance of the HAM-D scale at different points of assessment. A pvalue of <0.05 was considered a statistically significant difference and p-value of <0.01 was considered highly a statistically significant difference

Results

Basic characteristics of the cases

Typhoid carrier status was diagnosed in 15 patients, 8 males (53%) and 7 females (47%), the median age was 47 and the age range was 19-63 years. All patients were Egyptians and were referred to us from rural/villages area. Ten patients (66%) were not complaining of any chronic diseases while 3 (20%) were having DM, 4 (26%) were having HTN and 1 (6%) was suffering from bronchial asthma. As regarding smoking, six patients were smoker (40%) while 60% were not.

Clinical examination and imaging findings

Pallor and white coated tongue (Figure 1) were present in 12 patients (80%); right iliac fossa tenderness by deep palpation, using more than average pressure by overlapping hands was present in 13 (86%); mild splenomegaly (12-15 cm) in 8 (53%); hepatomegaly in 6 (40%); thick wall gall bladder in 12 (80%) and calculary gall bladder in 3 (20%). Repeated assessment at 6th week post antibiotic completion showed that pallor was present in 3 patients (20%); white coated tongue (Figure 1) in 2 (13%); right iliac fossa tenderness in 1 patient (6%); mild splenomegaly in 4 (26%); hepatomegaly in 6 (40%); thick wall gall bladder in 12 (80%) and calculary gall bladder in 3 (20%).

depression-and-anxiety-White-coated-tongue

Figure 1: White coated tongue.

Laboratory findings

The mean of leukocyte was 6.9 × 103/μL) and the standard deviation (SD) was (3.6). The mean of haemoglobin was 12.4 gm/dl and the SD was (1). The mean platelet count was 329.1× 103/μL) and the SD was (159). The mean of ALT was 46 (IU/ml) and the SD was (19.5). The mean of AST was 42.5 (IU/ml) and the SD was (14.1). The mean of serum creatinine was 1.1 (mg/dL) and the SD was (0.2). The mean of CRP was 4 mg/L and the SD was 1.3. The mean of ESR was 16.1 ml/hr. and the SD was 8.6. Widal test was positive in 13 patients (86%). We used a cut-off value of 1/160 for either “O” or “H” antigen as positive Widal test.

Bacterial isolates

This was the most time-consuming factor in our study, as the excretion of Salmonella in typhoid carriers are intermittent and accordingly the possibility of catching it from one sample is considerably low, accordingly this limits the number of patients enrolled and prolong the study time to > 2 years. However, in our routine practice we decided to depend on clinical assessment supplemented by Widal test positivity to initiate antibiotic treatment, even in stool culture negative patients, yet without reporting our finding for reliability issue, see discussion section. Salmonella typhi was isolated in 10 patients (66%) and Salmonella Para-typhi A in 5 patients (33%). No isolate for S. para-typhi B/C was found.

Duration of carriage

We didn’t classify our patients based on carriage time (see discussion section), however our series was composed of 5 patients (33%) with chronic carriage > 1 year; 8 patients (53%) with temporarily, 3 months-1 year and 1 patient (6%) with Convalescent, 3 weeks-3 months. Table 1 shows basic, clinical, laboratory, radiological and microbiological data.

Presenting somatic complaints

Table 2 shows the frequency of somatic complaints at presentation and at 6th week post antibiotic completion. The changes in the presenting somatic complaints were highly statistically significant pvalue< 0.01. It shows that fatigue and myalgia were present in 15 (100%) patient, anorexia in 12 (80%), chronic abdominal pain in 11 (73%), change in bowel habits in 13 (86%), vomiting in 6 (40%), myalgia in 7 (46%), atypical chest pain in 4 (26), palpitations in 9 (60%), dyspnea in 8 (53%),urinary frequency in 6 (40%), erectile dysfunction in 4 out of 8 males (50%), while menstrual disturbance was present in 3 out of 7 females (42%). At the 6th week point the figures and percentages were 1 (6%), 3 (20%), 4 (26%), 7 (46%), 6 (40%), 0 (0%), 0 (0%), 1 (6%), 2 (13%), 1 (6%), 3 (20%), 1 (6%) and unapplicable, respectively. By un-applicability we mean that we reevaluated the patients after 6 weeks which is too short time for assessing menstruation.

Symptoms Before At 6th week point p-value
Fatigue 15 (100%) 1 (6%) <0.001*
Headache 15 (100%) 3 (20%) <0.001*
Anorexia 12 (80%) 4 (26%) <0.001*
Change in bowel habits 13 (86%) 7 (46%) <0.001*
Chronic/recurrent abdominal pain 11 (73%) 6 (40%) <0.001*
Vomiting 6 (40%) 0 (0%) <0.001*
Myalgia 7 (46%) 0 (0%) <0.001*
Atypical chest pain 4 (26%) 1 (6%) <0.001*
Palpitations 9 (60%) 2 (13%) <0.001*
Dyspnea 8 (53%) 1 (6%) <0.001*
Urinary frequency/dysuria 6 (40%) 3 (20%) <0.001*
Erectile dysfunctions 4 (50%) 1 (6%) <0.01*
Menstrual disturbances 3 (42%) UA  -

Table 2: Frequency of somatic complaints at presentation and 6 weeks post-treatment. p-value <0.01* is considered as statistically highly significant.

Hamilton-D (HAM-D) scale changes with antibiotic treatment

Figure 2 shows the classification of depression, based on Ham-D scale at the presentation, 2 weeks and 6th week points.

depression-and-anxiety-depression-severity

Figure 2: Changes in depression severity during study time.

At presentation, all patients were having severe depression; while at the end of antibiotic treatment only 1 patient (7%) still was having severe depression, 8 patients (53%) were having moderate depression and mild depression was present in 6 patients (40%). By the 6th week post treatment completion, no patients were having severe depression, 5 patients (33%) showed moderate depression, 6 patients (40%) exhibited mild depression and 4 patients (27%) were normal.

Table 3 and Figure 3 shows the changes in the means of HAM-D scale with treatment; which signified statistically significant differences of the mean of HAM-D scale at the 3 points of evaluations, pvalue< 0.01 for each pair.

depression-and-anxiety-Box-plots

Figure 3: Box plots demonstrating changes in HAM-D scale in patients during evaluation points.

Variables Minimum Maximum Mean Std. Deviation Paired Samples t-test p-value
t df
HAM-D before treatment 18 23 20.8 1.61245 7.267 14 <0.001*
HAM-D at end of treatment 10 21 14.2667 3.08143 8.119 14 <0.001**
HAM-D at 6th week post treatment completion 5 18 11.2 4.00357 4.258 14 <0.001***
* for comparing HAM-D before treatment and at the end of treatment; ** for comparing HAM-D before treatment and at the end of treatment; *** for comparing HAM-D at the end of treatment and at 6th week post treatment completion.

Table 3: Changes in HAM-D scale with treatment.

Discussion

To the best of our knowledge, this is the first report about the association between typhoid carriage and low mood. Our report showed that all cases with typhoid carrier states were presented by severe depression, based on HAM-D scale, with very statistically significant improvement in their depression scale, solely after antibiotic treatment. The improvement in depression scale was evident immediately after completion of antibiotic courses and consolidates at the 6th-week post antibiotic completion point of evaluation. It also shows that the improvement of the presenting somatic complaints was statistically very significant (Table 2).

This series reporting is inconsistent with most of the previous reports, which acknowledge that most of typhoid carriers in endemic areas are asymptomatic and up to 25% of them have no history of typhoid fever [21,22].

Previous studies dealing with typhoid carrier tried to separate between convalescent, temporary and chronic carriers. Convalescent carriers excrete the bacterium in feces for three weeks to three months post-infection, temporary excrete for between three and twelve months, and chronic for more than one year [22]. This separation is mainly for epidemiological interest; however, we didn’t think that this distinction would be of clinical interest in term of depression, as all categories in our series presented and responded similarly.

We didn’t include Widal test in our criteria for enrolment, because of the unreliability and non-validity of it; however it still represents a very important clinical tool in diagnosis of acute typhoid fever in developing countries, like Egypt [23]. If we had included it, the number of cases reported in this series would be multiplied many times, because it is widely used in diagnosis of typhoid fever in our country, and we faced many patients with clinical history of typhoid fever, yet their diagnosis was based only on the positivity of Widal test, without confirmation by culturing the bacterium. Also, many patients were having a clear history of typhoid fever that was diagnosed by culturing, yet we failed to find Salmonella organisms in stool culture at the enrolment time, accordingly failed to prove their carrier states. Those patients were excluded from reporting, however we treated them in the same manner, and they responded in same way.

Many typhoid carriers are excretory only of S. typhi [24], however the bacteria isolated in our series was S. typhi in 10 patients and paratyphi- A in 5 patients, representing about 66% and 33%, respectively. This isn’t a real paradox, because S. para-typhi was also isolated from the gall bladder of Nepali patients [25]. Abnormal gall bladder in imaging was prevalent in our series with thick wall gall bladder present in 12 (80%) and calcular gall bladder in 3 (20%). This is consistent with previous reports [26-28]. White coated tongue was found to be highly specific for acute enteric fever in a study by Haq et al. [29] in our study it was found in 80% of patients in spite of being afebrile. Right iliac fossa tenderness and mesenteric adenitis or even appendicitis, are known to be a presenting feature of enteric fever [30-33].

In our series, right iliac fossa tenderness by deep palpation using more than average pressure by overlapping hands was found in 13 (86%) of patients. The tenderness elicited wasn’t associated with any peritoneal irritation signs. We incriminate the ileum as a site for carriage which results in local inflammation and tenderness. Likewise, the mild splenomegaly (12-15 cm) presented in 53% of our patients, best explained by the local chronic inflammation in terminal ileum. Depression is a heterogenous disorder with multiple psychosocial, immunological, infectious and biological risk factors.

The role of inflammation in depression has been extensively studied over the past decades. Peripheral blood and cerebrospinal fluid (CSF) of patients with major depressive illness, were found to have increasing expression of inflammatory cytokines, their receptors, acute phase reactants and soluble cell adhesion molecules [10,34,35]. There are clear evidences from meta-analysis about the association of peripheral blood level of IL-1β, IL-6, TNF and C-reactive protein (CRP) with depression [10]. Polymorphisms in the genes of the inflammatory cytokines; IL-1β, TNF and CRP were associated with depression and its response to treatment [36]. Patients treated with the inflammatory cytokine; interferon-α, developed clinically significant depression [13,14]. Likewise, patients treated anti-TNF, including rheumatoid arthritis, psoriasis and cancer showed improvement in their depression symptoms [37-39]. Patients with treatment-resistant depression whom were having high levels of inflammatory markers responded to anti- TNF with improvement in their depression severity [40]. Also, uncontrolled inflammation has been associated in many studies, with poor response to anti-depressants [41-43].

One model explaining the association between inflammation and depression is the “Pathogen host defense theory”, according to it the strong selective pressure by microbial exposure, promoted selection of pro-inflammatory alleles, which in turn are associated with initiation of depressive behaviors. The negative depressive behaviors; the social avoidance and anhedonia characteristic of depression, aren’t considered bystanders, rather protective through shunting energy sources towards combating infections [42,44].

Many infectious agents have been suspected as risk factors for depression, including enterovirus, human immunodeficiency virus, hepatitis C virus, varicella-zoster virus, human T-cell lymphotropic virus, herpes simplex 1, Epstein-Barr virus, Borna disease virus, Brucellosis and Chlamydophila trachomatis [45-52]. Typhoid fever is well known to be associated with depression and this was documented in previous reports [15-17].

Recently, typhoid vaccine was used in experimental models for induction of inflammatory states associated with low mood [18,19]. This evolving association between typhoid vaccine using only a single subcutaneous polysaccharide antigen, puts strong criticisms in the asymptomatic model of Salmonella carriers, when the subjects excrete Salmonella intermittently for prolonged ill-defined period. Our series criticize this asymptomatic model. We showed that all 15 patients with documented typhoid carrier states were suffering from low mood associated with somatic complaints, and this improved after documenting the clearance of carrier states. One can look to our results as a support for the growing theory of approaching depression; “the leaky gut hypothesis” which assumes that infection of intestinal epithelium by gram negative bacteria makes the intestinal epithelium leaky to the inflammatory cytokines that promote depression. In supporting of this, is the finding of an elevated serum IgM and IgA against lipopolysaccharides (LPS) of the gram negative enterobacteria in depressed patients [52,53].

Likewise, the leaky gut was implicated in pathogenesis and clinical severity of schizophrenia, and this was thought to be mediated by the inflammatory cytokines [54-57].

We postulate that the intermittent excretion of Salmonella bacteria by the typhoid carrier patients result local intestinal inflammatory reactions that damage the epithelium allowing the inflammatory cytokines to translocate. It is the inflammatory cytokines that results in depression. However, we didn’t measure the inflammatory cytokines in our series, and this is a limiting factor in our finding. We recommend further studies measuring the inflammatory cytokines in typhoid carriers and correlating it with low mood before and after clearance of the carrier states.

Conclusion and Limitations

Instead of the traditional asymptomatic view for typhoid carrier state, we present “the chronic infection model”; the patients are chronically infected, yet afebrile and the chronic infection is reflected as “psycho-somatic depression”. Other limitations of our study are the relatively small number of the patients and the relatively short time of follow-up. We recommend further studies using large number and following the patients for prolonged durations. We acknowledge that our results are inconsistent with the traditional view for typhoid carriers as asymptomatic populations, and we don’t expect this view to be changed based on a series of 15 patients; however, we encourage physicians in endemic countries to report similar associations.

Finally, during our work we were faced by the fact that diagnosis of Salmonella carriers is difficult due to the intermittent nature of excretions and especially in developing countries where the accessibility for accurate stool cultures is restrained and the unreliability of the widely available Widal test. We encourage further tests development for detections of Salmonella carriers.

Conflict of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper

Funding Statement

We did not receive any fund.

Data Availability Statement

All data are available upon request.

References

  1. Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346-353.
  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
  3. Levine MM, Black RE, Lanata C (1982) Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 146: 724-726.
  4. Gonzalez-Escobedo G, Marshall JM, Gunn JS (2011) Chronic and acute infection of the gall bladder by Salmonella typhi: Understanding the carrier state. Nat Rev Microbiol 9: 9-14.
  5. UstunTB, Rehm J, Chatterji S, Saxena S, Trotter R, et al. (1999) Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. Lancet 354: 111-115.
  6. Murray CJ, Lopez AD (1996) Evidence-based health policy--lessons from the Global Burden of Disease Study. Science 274: 740-743
  7. Dickens C, McGowan L, Clark-Carter D, Creed F (2002) Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosom Med. 64: 52-60.
  8. Felger JC, Lotrich FE (2013) Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience 246: 199-229.
  9. Pillai V, Kalmbach DA, Ciesla JA (2011) A meta-analysis of electroencephalographic sleep in depression: Evidence for genetic biomarkers. Biol Psychiatry 70: 912-919.
  10. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65: 732-741.
  11. Dahl J, Ormstad H, Aass HC, Malt UF, Bendz LT, et al. (2014) The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 45: 77-86.
  12. Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, et al. (2010) Association of high sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 197: 372-377.
  13. Taylor MJ, Godlewska B, Near J, Christmas D, Potokar J, et al. (2014) Effect of interferon-α on cortical glutamate in patients with hepatitis C: a proton magnetic resonance spectroscopy study. Psychol Med 44: 789-795.
  14. Udina M, Hidalgo D, Navinés R, Forns X, Solà R, et al. (2014) Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry 75: 1113-1121.
  15. Osuntokun BO, Bademosi O, Ogunremi K, Wright SG (1972) Neuropsychiatric manifestations of typhoid fever in 959 patients. Arch Neurol 27: 7-13. 
  16. Venkatesh S, Grell GA (1989) Neuropsychiatric manifestations of typhoid fever. West Indian Med J 38: 137-141. 
  17. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, et al. (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 66: 407-414
  18. Wright C, Strike PC, Brydon L, Steptoe A (2005) Acute inflammation and negative mood: Mediation by cytokine activation. Brain Behav Immun 19: 345-352.
  19. Hamilton M (1960) A rating scale for depression J Neurol Neurosurg Psychiatry 23: 56-62.
  20. Mortimer PP (1999) Mr N. The milker, and Dr. Koch's concept of the healthy carrier. The Lancet 353: 1354-1356.
  21. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ (2002) Typhoid fever. N Engl J Med 347: 1770-1782.
  22. Olopoenia LA, King AL (2000) Widal agglutination test--100 years later: Still plagued by controversy. Postgrad Med J 76: 80-84.
  23. Roumagnac P, François-Xavier W, Dolecek C, Baker S, Brisse S, et al. (2006) Evolutionary history of Salmonella typhi. Science. 314: 1301-1304.
  24. Dongol S, Thompson CN, Clare S, Nga TVT, Duy PT, et al. (2012) The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in Kathmandu, Nepal. PLOS One 7: e47342.
  25. Schiøler H, Christiansen ED, Hoybye G, Rasmussen SN, Greibe J (1983) Biliary calculi in chronic Salmonella carriers and healthy controls: a controlled study. Scand J Infect Dis 15: 17-19.
  26. Karaki K, Matsubara Y (1984) Surgical treatment of chronic biliary typhoid and paratyphoid carriers. Nippon Shokakibyo Gakkai Zasshi 81: 2978-2985.
  27. Lai CW, Chan RC, Cheng AF, Sung JY, Leung JW (1992) Common bile duct stones: A cause of chronic salmonellosis. Am J Gastroenterol 87: 1198-1199. 
  28. Haq SA, Alam MN, Hossain SM, Ahmed T, Tahir M (1997) Value of clinical features in the diagnosis of enteric fever. Bangladesh Med Res Counc Bull 23: 42-46.
  29. Martin HC, Goon HK (1986) Salmonella ileocaecal lymphadenitis masquerading as appendicitis. J Pediatr Surg 21: 377-378.
  30. Likitnukul S, Wongsawat J, Nunthapisud P (2002) Appendicitis-like syndrome owing to mesenteric adenitis caused by Salmonella typhi. Ann Trop Paediatr 22: 97.
  31. García-Corbeira P, Ramos JM, Aguado JM (1995) Six cases in which mesenteric lymphadenitis due to non-typhi Salmonella caused an appendicitis-like syndrome. Clin Infect Dis 21: 231-232.
  32. Meng GR (1974) Acute mesenteric lymphadenitis due to Salmonella enteritidis mimicking appendicitis: A case report. Mil Med 139: 277.
  33. Andrew H, Raison CL (2016) The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nat Rev Immunol 16: 22-34.
  34. Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, et al. (2000) Illness, cytokines, and depression. Ann NY Acad Sci 917: 478-487.
  35. Bufalino C, Hepgul N, Aguglia E, Pariante CM (2012) The role of immune genes in the association between depression and inflammation: A review of recent clinical studies. Brain Behav Immun 31: 31-47.
  36. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, et al. (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. The Lancet 367: 29-35.
  37. Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, et al. (2015) Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res 79: 175-84.
  38. Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, et al. (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71: 1381-1391.
  39. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, et al. (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31-41.
  40. Slavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol Bull 140: 774-815.
  41. Eurelings LS, Richard E, Eikelenboom P, Van Gool WA, Moll Van Charante EP (2015) Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individuals. Int Psychogeriatr 27: 639-647.
  42. Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, et al. (2003) Candidate genes expression profile associated with antidepressants response in the GENDEP study: Differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology 38: 377-385.
  43. Raison CL, Miller AH (2013) The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry 18: 15-37.
  44. Liao YT, Hsieh MH, Yang YH, Wang YC, Tsai CS, et al. (2017) Association between depression and enterovirus infection. Medicine 96: e5983.
  45. Coughlin SS (2012) Anxiety and depression: Linkages with viral diseases. Public Health Rev 34: 92.
  46. Lucaciu LA, Dumitrascu DL (2015) Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment. Ann Gastroenterol 28: 440-447.
  47. Chen MH, Wei HT, Su TP, Li CT, Lin WC, et al. (2014) Risk of depressive disorder among patients with herpes zoster: A nationwide population-based prospective study. Psychosom Med 76: 285-291.
  48. Stumpf BP, Carneiro-Proietti AB, Proietti AF, Rocha FL (2008) Higher rate of major depression among blood donor candidates infected with human t-cell lymphotropic virus type 1. Int J Psychiatry Med 38: 345-355.
  49. Wang X, Zhang L, Lei Y, Liu X, Zhou X, et al. (2014) Meta-Analysis of infectious agents and depression. Sci Rep 4: 4530.
  50. Mandel GL (2010) Douglas and Bennett’s Principles and practice of infectious diseases. (7th edn). Philadelphia, PA: Churchil Livingtone, Elsivier : 2921-2924.
  51. Maes M, Kubera M, Leunis JC, Berk M (2012) Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord 141: 55-62.
  52. Maes M, Kubera M, Leunis JC (2008) The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29: 117-124.
  53. Fan X, Goff DC, Henderson DC (2007) Inflammation and schizophrenia. Expert Rev Neurother 7: 789-796.
  54. Fan X, Liu EY, Freudenreich O, Park JH, Liu D, et al. (2010) Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res 118: 211-217.
  55. Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, et al. (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145: 36-42.
  56. Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD (2008) Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 63: 1022-1029.
Citation: Bakeer MS, Hussein MS, El-Gendy AAA, Abouzed M (2018) A Case Series for Salmonella Carriers Who Presented with Psychosomatic Depressive Disorder and Showed Improvement after Ceftriaxone Treatment for 15 Days. J Depress Anxiety 7: 317.

Copyright: © 2018 Bakeer MS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top